Showing results (131-140 of 152) with videos related to
Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell TherapyRoni Shouval, Ana Alarcon Tomas, Joshua A Fein, et al.The Lancet. Haematology|February 26, 2021
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registryRoni Shouval, Joshua A Fein, Myriam Labopin, et al.Neuro-Oncology|May 5, 2017
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendrogliomaAlissa A Thomas, Lauren E Abrey, Robert Terziev, et al.Blood Advances|August 26, 2020
Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agentsLindsey E Roeker, Peter Dreger, Jennifer R Brown, et al.Blood Advances|September 8, 2021
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndromeAlex F Herrera, Kwang Woo Ahn, Carlos Litovich, et al.Leukemia & Lymphoma|April 2, 2020
The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patientsRichard J Lin, Laure Michaud, Stephanie M Lobaugh, et al.The Journal of Clinical Investigation|September 8, 2020
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantationGunjan L Shah, Susan DeWolf, Yeon Joo Lee, et al.The Journal of Clinical Investigation|March 23, 2023
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplantSusan E Prockop, Aisha Hasan, Ekaterina Doubrovina, et al.Blood Advances|July 24, 2025
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysisNausheen Ahmed, Swetha Thiruvengadam, Mehdi Hamadani, et al.Blood Advances|December 8, 2020
High progression-free survival after intermediate intensity double unit cord blood transplantation in adultsJuliet N Barker, Sean M Devlin, Kristine A Naputo, et al.Pageof 16